Literature DB >> 14588117

Spinal cord injury induces lesional expression of the proinflammatory and antiangiogenic cytokine EMAP II.

Christian-Andreas Mueller1, Hermann J Schluesener, Sabine Conrad, Richard Meyermann, Jan M Schwab.   

Abstract

Inflammatory cellular responses to spinal cord injury are promoted by proinflammatory messengers. We have analyzed expression of endothelial monocyte activating polypeptide II (EMAP II), a proinflammatory, antiangiogenic cytokine in rats after spinal cord injury (SCI) in comparison to normal rat spinal cords. Immunohistochemical analysis demonstrated a highly significant (p < 0.0001) accumulation of EMAP II(+) microglia/macrophages at the lesion site compared to remote areas and uninjured controls. After peaking at day 3, EMAP II(+) microglia/macrophage cell numbers declined gradually until day 28 after SCI-but still remained elevated. Further, EMAP II(+) cells formed clusters in perivascular Virchow-Robin spaces reaching a maximum at day 3. Prolonged accumulation of EMAP II(+), ED1(+) microglia/macrophages suggest a role of EMAP II in the pathophysiology of secondary injury following SCI.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14588117     DOI: 10.1089/089771503770195858

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  7 in total

1.  Dilated perivascular spaces: hallmarks of mild traumatic brain injury.

Authors:  Matilde Inglese; Elan Bomsztyk; Oded Gonen; Lois J Mannon; Robert I Grossman; Henry Rusinek
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

Review 2.  Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II).

Authors:  Charitharth Vivek Lal; Margaret A Schwarz
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-03-12

3.  Expression of endothelial monocyte-activating polypeptide II in the rat dental follicle and its potential role in tooth eruption.

Authors:  Dawen Liu; Gary E Wise
Journal:  Eur J Oral Sci       Date:  2008-08       Impact factor: 2.612

4.  P43/pro-EMAPII: a potential biomarker for discriminating traumatic versus ischemic brain injury.

Authors:  Changping Yao; Anthony J Williams; Andrew K Ottens; X-C May Lu; Ming Cheng Liu; Ronald L Hayes; Kevin K Wang; Frank C Tortella; Jitendra R Dave
Journal:  J Neurotrauma       Date:  2009-08       Impact factor: 5.269

5.  Postulated vasoactive neuropeptide immunopathology affecting the blood-brain/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?

Authors:  Donald R Staines; Ekua W Brenu; Sonya Marshall-Gradisnik
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

Review 6.  Postulated role of vasoactive neuropeptide-related immunopathology of the blood brain barrier and Virchow-Robin spaces in the aetiology of neurological-related conditions.

Authors:  D R Staines; E W Brenu; S Marshall-Gradisnik
Journal:  Mediators Inflamm       Date:  2009-02-16       Impact factor: 4.711

7.  FTY720 attenuates accumulation of EMAP-II+ and MHC-II+ monocytes in early lesions of rat traumatic brain injury.

Authors:  Zhiyuan Zhang; Zhiren Zhang; Uwe Fauser; Matthias Artelt; Michael Burnet; Hermann J Schluesener
Journal:  J Cell Mol Med       Date:  2007 Mar-Apr       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.